Severe acute respiratory syndrome coronavirus 2 (ID 658321) - BioProject

Format

Choose Destination

Accession: PRJNA658321 ID: 658321

Severe acute respiratory syndrome coronavirus 2

See Genome Information for Severe acute respiratory syndrome-related coronavirus

Navigate Up

Navigate Across

407 additional projects are related by organism.

961 additional projects are components of the INSDC SARS-CoV-2 Viral Sequencing Data.

Sequencing of SARS-CoV-2 clinical isolates from patients in Scotland.

Accession	PRJNA658321
Data Type	Genome sequencing
Scope	Multiisolate
Organism	Severe acute respiratory syndrome coronavirus 2[Taxonomy ID: 2697049] Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes; Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae; Betacoronavirus; Sarbecovirus; Severe acute respiratory syndrome-related coronavirus; Severe acute respiratory syndrome coronavirus 2
Publications	Rihn SJ et al., "A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.", PLoS Biol, 2021 Feb;19(2):e3001091
Submission	Registration date: 20-Aug-2020 MRC-University of Glasgow Centre for Virus Research
Locus Tag Prefix	H8Z84

Project Data:

Parameter	Value
Data volume, Gbases	52
Data volume, Mbytes	24169

Supplemental Content

Severe acute respiratory syndrome coronavirus 2
Severe acute respiratory syndrome coronavirus 2
Severe acute respiratory syndrome coronavirus 2 Genome sequencing

BioProject
Severe acute respiratory syndrome coronavirus 2 strain:Gamma
Severe acute respiratory syndrome coronavirus 2 strain:Gamma
Severe acute respiratory syndrome coronavirus 2 strain:Gamma Raw sequence reads

BioProject
SARS-CoV-2 point mutation and deletion spectra, and their association with diffe...
SARS-CoV-2 point mutation and deletion spectra, and their association with different disease outcome
The study shows that mutant spectra of SARS-CoV-2 from diagnostic samples differed in point mutation abundance and complexity, and that significantly larger values were recorded in virus from patients who developed mild COVID-19 symptoms. The abundance of low frequency mutations marks a difference with other RNA viruses, and it may slow down the response of SARS-CoV-2 to escape specific selective constraints such as drugs or antibodies.

BioProject
undefined
undefined
A comparison of high-throughput SARS-CoV-2 sequencing methods using COVID-19 patient samples

BioProject

Your browsing activity is empty.

Activity recording is turned off.